Medtronic has announced FDA approval and U.S. commercial availability of its free MyCareLink Smart Monitor. The smart mobile application in combination with the prescribed handheld device reader will ...

A pacemaker from Medtronic, newly approved by the Food and Drug Administration, allows patients to securely transmit data from the pacemaker to their physicians via a smartphone or tablet using ...

The Cybersecurity and Infrastructure Security Agency warned of vulnerabilities within Medtronic’s MyCareLink Smart device, which monitors pacemaker activity and sends information to clinicians. 1. The ...

FDA Approves New ICDs and CRT-Ds with Advanced Remote Capabilities DUBLIN, May 08, 2020 (GLOBE NEWSWIRE) -- Medtronic plc (NYSE:MDT) today announced results from late-breaking clinical trials ...

Medtronic has received FDA clearance for a mobile app that allows patients to remotely forward data from their pacemakers with their physicians. The app is paired with a device, the MyCareLink Smart ...

The FDA recently approved a new device from Medtronic that turns a smartphone into a patient’s pacemaker monitor that can send stats to their doctor in real time. The MyCareLink Smart Monitor is able ...

The list of smartphone capabilities seems to expand daily and now, for patients with an implantable pacemaker from Medtronic Plc (Dublin), there is even a mobile app designed to monitor the device ...

Click to email a link to a friend (Opens in new window) Click to share on Facebook (Opens in new window) Click to share on Twitter (Opens in new window) Click to print (Opens in new window) Medtronic ...

DUBLIN, Jan. 5, 2024 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced it has received CE (Conformité Européenne) Mark for its Micra™ AV2 and Micra™ VR2, ...